Spero Therapeutics: Yesterday's Selloff On Utebzi Approval Seems Bewildering
Spero Therapeutics Inc SPRO
$2.28
▲ +8.06%
(+$0.17)
Open
$2.51
Prev Close
$2.11
Day Range
$2.15 – $2.51
52W Range
$1.80 – $3.22
Market Cap
$132.02M
P/E (TTM)
8.67
Beta
1.49
EPS (TTM)
$0.17
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-11-02 |
| Shares Out. | 57,900,000 |
| Website | sperotherapeutics.com/ ↗ |
| Phone | 13026587581 |
Spero Therapeutics Inc is a publicly traded company under the ticker symbol SPRO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-06-01)
📰 Latest News for SPRO
These stocks that are showing activity before the opening bell on Thursday.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Top movers in Wednesday's session
12 Health Care Stocks Moving In Wednesday's After-Market Session
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs
12 Health Care Stocks Moving In Wednesday's Intraday Session